ALX Oncology Inc.

ALXO | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.66

-$0.04 (-2.35%)

At close: Sep 21, 2026, 4:00 PM ET

$1.65

-$0.01 (-0.60%)

After-hours: Sep 21, 2026, 7:52 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $223.37M

Enterprise Value $94.85M

Beta 0.40

Average Volume 1.18M

Shares Outstanding (Diluted) 135.64M

Shares Change YoY 153.79%

Institutional Ownership 90.15%

Exchange NASDAQ

ISIN US00166B1052

Price Performance

Price Change 1M -17.0%

Price Change 3M -5.7%

Price Change 6M -18.6%

Price Change YTD 44.4%

Price Change 1Y 30.7%

Price Change 3Y -67.0%

Price Change 5Y -97.8%

1M CAGR (ann.) -20.9%

1Y CAGR (ann.) 52.3%

5Y CAGR (ann.) -53.7%

All-Time CAGR -37.4%

Valuation

PE Ratio -1.29

Forward PE N/A

PEG Ratio -0.02

Forward PEG 0.67

PS Ratio N/A

Forward PS 41.80

PB Ratio 1.64

P/FCF Ratio -2.49

P/Adj. FCF Ratio -2.18

P/OCF Ratio -3.19

EV/Sales N/A

EV/EBIT -1.18

EV/EBITDA -1.19

EV/FCF -1.06

Earnings Yield -77.7%

FCF Yield -40.1%

Adj. FCF Yield -45.9%

Financial Health

Net Cash $128.52M

Total Debt $9.71M

Cash & Short-Term Investments $138.23M

Total Assets $160.82M

Current Ratio 9.71

Quick Ratio 9.71

Debt / Equity Ratio 0.07

Debt / EBITDA -0.12

Debt / FCF -0.11

OCF / Debt -9.21

Interest Coverage -58.67

Altman Z-Score -1.85

Piotroski F-Score 4

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -14.4%

Returns

Return on Assets -50.3%

Return on Equity -90.3%

Return on Invested Capital -56.5%

Return on Capital Employed -56.5%

Return on Tangible Assets -50.3%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 49.4%

EPS CAGR 5Y 14.6%

EPS CAGR 10Y N/A

FCF CAGR 3Y 20.4%

FCF CAGR 5Y 0.1%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 7

EPS Growth Next 3Y 17.6%

Revenue Growth Next 3Y N/A

Earnings Date Nov 5, 2026

EPS Estimate (next Q) -$0.15

EPS Growth Est (next Q) -63.4%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $17.90

Price Target Upside 978.3%

Cash Flow

Operating Cash Flow $-89.43M

Free Cash Flow $-89.65M

Adj. Free Cash Flow $-102.58M

FCF Per Share -$0.52

OCF Per Share -$0.52

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-150K

Operating Income $-82.79M

EBITDA $-79.38M

Net Income $-80.89M

EPS (Diluted) -$1.29

Revenue / Employee N/A

Profit / Employee $-1.69M

Employees 48